What is the recommended systolic blood pressure target during the first 24 hours after successful mechanical thrombectomy?

Blood Pressure Target After Mechanical Thrombectomy

Maintain systolic blood pressure <180/105 mmHg for at least the first 24 hours after mechanical thrombectomy, regardless of whether the patient received concurrent IV thrombolysis.

Primary Recommendation

The 2024 ESC Guidelines provide the most current guidance: blood pressure should be carefully lowered and maintained at <180/105 mmHg for at least the first 24 hours after mechanical thrombectomy 1. This represents a Class IIa recommendation with Level B evidence, reflecting the increased risk of reperfusion injury and intracranial hemorrhage in patients undergoing reperfusion therapy.

The 2018 AHA/ASA Guidelines similarly recommend maintaining BP ≤180/105 mmHg during and for 24 hours after the procedure 2. This target applies whether or not the patient received IV thrombolysis beforehand.

Key Considerations Based on Reperfusion Success

For Successful Reperfusion (mTICI ≥2b)

The evidence becomes more nuanced when reperfusion is successful:

• The 2018 AHA/ASA Guidelines suggest it might be reasonable to maintain BP at a level <180/105 mmHg after successful reperfusion (Class IIb, Level B-NR) 2
• Some trial protocols (DAWN) recommended maintaining systolic BP <140 mmHg in the first 24 hours in patients who achieved successful reperfusion 2

However, recent high-quality research challenges more intensive targets:

The 2025 ENCHANTED2/MT secondary analysis (the most recent and highest quality study) found that achieving SBP of 120-140 mmHg within 24 hours was associated with better functional outcomes compared to 140-180 mmHg 3. This study showed improved mRS scores, lower neurological deterioration at 7 days, and reduced 90-day mortality with the lower target.

But this is contradicted by:

A 2024 meta-analysis demonstrated that intensive BP targets (<140 mmHg) were associated with worse neurological recovery, decreased functional independence (mRS ≤2), and reduced independent ambulation compared to standard targets (<180 mmHg) 4.

A 2017 observational study found that achieving BP <160/90 mmHg was associated with lower 3-month mortality compared to permissive hypertension, and every 10 mmHg increment in maximum SBP increased mortality risk 5.

Practical Algorithm

For all patients post-thrombectomy in the first 24 hours:

1. Primary target: <180/105 mmHg (guideline-based, safest approach given mixed evidence)

2. If successful reperfusion achieved (mTICI ≥2b):

   • Consider targeting <160/90 mmHg as a moderate approach
   • This balances the mortality benefit seen in observational data 5 while avoiding the potential harms of very intensive control (<140 mmHg) 4

3. Monitor hourly for the first 24 hours, then every 30-60 minutes if above target 6

4. Avoid precipitous drops:

   • BP drops ≥40 mmHg within 1 hour are independently associated with worse functional outcomes and early neurological deterioration 7
   • Excessive acute drops (>70 mmHg) should be avoided 1

5. Maintain systolic BP >140 mmHg during the procedure to preserve collateral flow while the vessel remains occluded 2

Medication Choices

First-line agents for acute BP management include 6, 8:

• Labetalol 10-20 mg IV over 1-2 minutes (may repeat once)
• Nicardipine 5 mg/h IV, titrate up by 2.5 mg/h every 5-15 minutes (maximum 15 mg/h)
• Clevidipine 1-2 mg/h IV, titrate by doubling dose every 2-5 minutes (maximum 21 mg/h)

Critical Pitfalls to Avoid

1. Do not aggressively lower BP to <140 mmHg based on the conflicting evidence—this may worsen functional outcomes 4

2. Avoid rapid BP drops (≥40 mmHg within 1 hour), which are associated with early neurological deterioration 7

3. Do not allow permissive hypertension (>180/105 mmHg) in the post-thrombectomy period, as this increases mortality risk 5

4. Monitor for hypotension during the procedure, as low BP may compromise collateral perfusion 9

After 24 Hours

• If BP remains <180/105 mmHg in the first 72 hours, patients do not benefit from introduction or reintroduction of BP-lowering medication 1
• For stable patients remaining hypertensive (≥140/90 mmHg) ≥3 days after stroke, initiate or reintroduce BP-lowering medication for secondary prevention 1

Evidence Quality Note

The guideline recommendations are based on limited RCT data specific to mechanical thrombectomy 1, 2. Most evidence comes from trials where patients also received IV thrombolysis. The 2026 Cochrane review found that intensive BP management (<160 mmHg) results in little to no difference in most outcomes but probably increases all-cause mortality 10, supporting a more conservative approach to BP lowering post-thrombectomy.